Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-9-20
|
pubmed:abstractText |
BP-1 antibody recognizes a cell surface molecule related to the zinc-dependent metallopeptidases that is expressed during a narrow window early in B cell differentiation. Expression of the same molecule, as originally recognized by the mAb 6C3, is widely accepted to be associated with the complete malignant transformation of pre-B lymphoid cells. We have examined BP-1/6C3 expression in a panel of established Abelson virus-transformed cells that includes both cells analogous to pre-B cells and to less differentiated B lineage cells that have not yet completed Ig H chain gene rearrangement. This analysis reveals that many of the less differentiated transformants do not express BP-1/6C3 for an extended culture period. In contrast, virtually all transformants that are analogous to normal pre-B cells express the determinant early in their culture history. The BP-1/6C3 negative transformants are fully tumorigenic in syngeneic mice, demonstrating that BP-1/6C3 expression is not required for complete malignant transformation. Our data thus suggest that the pattern of BP-1/6C3 expression in Abelson virus-transformed cells mimics that observed in normal cells and is indicative of a differentiation event unrelated to the malignant potential of the cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1603-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1974567-Abelson murine leukemia virus,
pubmed-meshheading:1974567-Aminopeptidases,
pubmed-meshheading:1974567-Animals,
pubmed-meshheading:1974567-Antibodies, Monoclonal,
pubmed-meshheading:1974567-Antigens, CD13,
pubmed-meshheading:1974567-Antigens, Differentiation, B-Lymphocyte,
pubmed-meshheading:1974567-B-Lymphocytes,
pubmed-meshheading:1974567-Cell Differentiation,
pubmed-meshheading:1974567-Cell Transformation, Viral,
pubmed-meshheading:1974567-Gene Expression,
pubmed-meshheading:1974567-Gene Rearrangement, B-Lymphocyte, Heavy Chain,
pubmed-meshheading:1974567-Mice,
pubmed-meshheading:1974567-Neoplasms, Experimental,
pubmed-meshheading:1974567-Oncogenes
|
pubmed:year |
1990
|
pubmed:articleTitle |
BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential.
|
pubmed:affiliation |
Immunology Graduate Program, Tufts University School of Medicine, Boston, Massachusetts 02111.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|